France· FR:66029390
TANAKAN 40 mg/ml, solution buvable
A medicinal product containing extrait sec raffiné et quantifié de feuille de ginkgo, registered in France by MAYOLY PHARMA FRANCE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- EXTRAIT SEC RAFFINÉ ET QUANTIFIÉ DE FEUILLE DE GINKGO
- Manufacturer
- MAYOLY PHARMA FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009316324051 flacon(s) en verre jaune(brun) de 30 ml avec mesurette(s) graduée(s)
- cip1334009330279951 flacon(s) en verre jaune(brun) de 90 ml avec mesurette(s) graduée(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Extrait sec raffiné et quantifié de feuille de ginkgo in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandGinkgo Sandoz
- PolandBilobil IntenseKrka, d.d., Novo mesto
- United StatesGinkgo BilobaHahnemann Laboratories, INC.
- CzechiaTANAKANMayoly Pharma France, Rueil-Malmaison
- FinlandGeriaforce Neidonhiuspuu-Uute
- BelgiumTanakanIpsen
- GermanySynapsanBeh Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Germany · Synapsan
- Denmark · Bio-Biloba
- Estonia · Bio-Biloba
- Spain · Incebral
- Croatia · Bilobil Intense
- Hungary · Tebofortan
- Poland · Ginkgofol
- Portugal · Abolibe Forte, Biloban
- Slovakia · Gingio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c20dc020-f484-4caa-acc3-84c9092f61ea GET /v1/drugs/c20dc020-f484-4caa-acc3-84c9092f61ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66029390",
"date_amm": "1990-02-05",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "EXTRAIT SEC RAFFINÉ ET QUANTIFIÉ DE FEUILLE DE GINKGO",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about extrait sec raffiné et quantifié de feuille de ginkgo.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.